Synthetic Biologics is a biotechnology company focused on the development of biologics for the prevention and treatment of serious infectious diseases. The company is developing an oral enzyme for the prevention of C. difficile infections, and a series of monoclonal antibody therapies for the treatment of Pertussis and Acinetobacter infections. In addition, SYN is developing a drug candidate for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis. For more information visit the company’s Web site at www.syntheticbiologics.com
Let us hear your thoughts below: